Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVA993A | — |
Menveo to a pair of twins, and the dosage was 0.5. But it had expired 31-Dec-2024; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 18-year-old patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA993A, expiry date 31-DEC-2024) for prophylaxis. On 31-JAN-2025, the patient received Menveo .5 ml. On 31-JAN-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo to a pair of twins, and the dosage was 0.5. But it had expired 31-Dec-2024). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 31-JAN-2025 The registered nurse reported they had a medical assistant that administered Menveo to a pair of twins (patients), but it had expired, which led to an expired vaccine used. The reporter wanted to know what to do about this situation. The vaccine administration facility was the same as primary reporter. This case was linked with US2025013442, reported by the same reporter for different patient (second twin).; Sender's Comments: US-GSK-US2025013442:twin patients with same initials